• OPEN AN ACCOUNT
Indian Indices
Sensex
73,580.54 -1,247.71
( -1.67%)
Global Indices
Nasdaq
51,527.73 -356.96
(-0.69%)
Dow Jones
7,726.85 -58.79
(-0.76%)
Hang Seng
65,657.92 638.97
(0.98%)
Nikkei 225
10,716.75 8.42
(0.08%)
Forex
USD-INR
95.65 -0.17
(-0.17%)
EUR-INR
109.56 -0.37
(-0.34%)
GBP-INR
127.74 -0.44
(-0.34%)
JPY-INR
0.61 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Aditya Vision Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
540205
INE679V01027
53.3089438
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AVL
57.59
8068.55
EPS(TTM)
Face Value()
Div & Yield %
10.85
1
0.2
 

Valiant Laboratories consolidated net profit rises 151.43% in the March 2026 quarter
May 15,2026
Net profit of Valiant Laboratories rose 151.43% to Rs 1.76 crore in the quarter ended March 2026 as against Rs 0.70 crore during the previous quarter ended March 2025. Sales rose 59.16% to Rs 91.98 crore in the quarter ended March 2026 as against Rs 57.79 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 3.27 crore in the year ended March 2026 as against net loss of Rs 2.20 crore during the previous year ended March 2025. Sales rose 78.04% to Rs 237.47 crore in the year ended March 2026 as against Rs 133.38 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales91.9857.79 59 237.47133.38 78
OPM %5.236.61 -2.69-3.50 -
PBDT3.971.46 172 6.810.58 1074
PBT1.050.94 12 0.77-1.51 LP
NP1.760.70 151 -3.27-2.20 -49